Clinical Trials Logo

Striae Distensae clinical trials

View clinical trials related to Striae Distensae.

Filter by:

NCT ID: NCT03377231 Completed - Stretch Mark Clinical Trials

Prevention and Treatment of Stretch Marks With Stratamark™

Start date: July 11, 2013
Phase: Phase 4
Study type: Interventional

Stretch marks (striae distensae) are a form of scarring that is a natural result of pregnancy, obesity and in some instances occur due to puberty or steroid use. For some people, the stretch marks do not cause a problem, but in many circumstances they can cause physical symptoms such as itchiness, tenderness and pain. For many people stretch marks are also embarrassing and can have detrimental effects on a patient's mood and self-esteem. Stretch marks that result from pregnancy most commonly occur on the abdomen, breasts and thighs. Topical silicone gel was developed nearly thirty years ago to be used in the treatment of widespread hypertrophic scars (abnormal scars, which may be red or raised/depressed itchy or painful). Since this time it has been used successfully on most scar types. . Since stretch marks are a form of scarring it is thought that topical silicone gel may be helpful for this scar type also. Stratamark™ has been developed using different forms of silicone polymers, in a gel format, that dries to form a very thin and flexible silicone gel sheet making it a convenient therapy for the treatment and prevention of stretch marks. The aim of this clinical research study is to prove or disprove the efficacy, safety and tolerability of Stratamark™ in the prevention and treatment of stretch marks. In addition, the knowledge gained from this study may be of benefit to many future patients

NCT ID: NCT02601105 Completed - Striae Distensae Clinical Trials

Topical Centella Asiatica and the Cosmetic Appearance of Stretch Marks

Start date: October 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to clinically evaluate the efficacy, safety as well as patient satisfaction in the use of topical Centella asiatica (CA) on the cosmetic appearance of stretch marks.

NCT ID: NCT02510768 Completed - Striae Distensae Clinical Trials

A Study to Evaluate the Efficacy of ELAPR in Women With Striae Distensae Alba

Start date: April 16, 2015
Phase: Phase 1
Study type: Interventional

The study is designed to evaluate the efficacy of two formulations of a cross-linked tropoelastin matrix given the product codes ELAPR002f and ELAPR002g (collectively referred to as ELAPR or ELAPR002) for the treatment of Striae Distensae (SD) alba when administered as intradermal implants.

NCT ID: NCT02126566 Completed - Striae Distensae Clinical Trials

Multiclear Treatment for Striae Distensae - A Pilot Study

Start date: July 2014
Phase: Phase 2
Study type: Interventional

Striae distensae is a common skin condition that rarely causes significant medical problems. However, it often results in a considerable amount of distress to those with the condition. Various modalities of treatments have been used for striae distensae but few have led to satisfactory results. More recently, newer techniques such as pulsed dye laser and radiofrequency devices have been used with modest results. There is still, however, paucity of data using light therapy for the treatment of this condition. Blue light therapy using the Multiclear device has been used successfully in the treatment of acne. In contrast, there is little data to suggest its use in the management of striae distensae. We aim to study the effects of blue light on the treatment of striae distensae and whether this can be used safely to manage this condition.

NCT ID: NCT01788748 Completed - Striae Clinical Trials

Evaluation of Fractional Bipolar Radiofrequency for the Treatment of Striae

Start date: February 2013
Phase: N/A
Study type: Interventional

This is an interventional open prospective randomized study, done in two sites. The main purpose of this study is to evaluate the efficacy of the combination of bipolar radiofrequency potentiated by an infrared light followed by fractional bipolar radiofrequency for the treatment of striae on the abdomen. In order to have a more complete and accurate study, each technology will also be evaluated separately. This will allow the comparison of the effect of each treatment, in monotherapy or combined.

NCT ID: NCT01186848 Completed - Stretch Marks Clinical Trials

Fractional Laser and Ultrasound for Striae Distensae

Start date: August 2010
Phase: N/A
Study type: Interventional

This was a prospective randomized controlled study comparing the efficacy of micro-focused ultrasound when used in conjunction with 1550-nm erbium-doped fractionated laser versus 1550-nm erbium-doped fractionated laser alone for treatment of striae distensae(stretch marks). Each side of thigh (or abdomen) was randomized to receive 1550nm-fractionated laser treatment every 2 weeks for a total of 4 treatments on one side and the contralateral side received micro-focused ultrasound treatment and 1550nm-fractionated laser alternatively every 2 weeks for a total of 4 treatments with site-match control area of baseline striae on each side. The primary outcome measure by two dermatologists blindly compared the two areas of striae distensae on each side from live subjects using a questionnaire and quartile rating scale on the final follow-up visit. This study was a pilot study designed to determine the feasibility of these procedures.

NCT ID: NCT01027793 Completed - Treatment Clinical Trials

Trial Comparing Treatment of Tretinoin or Superficial Dermabrasion for Stretch Marks

Start date: March 2009
Phase: Phase 4
Study type: Interventional

This study aims to evaluate head-to-head the effectiveness of tretinoin 0.5% and superficial dermabrasion in subjects that have recent stretch marks.